Sydney Lupkin

speaker
1,064 appearances 108 recordings 3 series first heard Dec 2024 last heard 4d ago

Sydney Lupkin’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
21 · Jul OctJan 26AprJulnow

Recordings per month over the last 12 months — 93 in all, peaking in Jul 2026 with 21.

Appearances

newest first · ▶ plays the moment
The catch is that you have to take this pill on an empty stomach and wait 30 minutes before eating anything else for it to work.
Yeah, I definitely heard from people who were like, pass.
The injection is working for me.
I'm good.
I don't want this.
But others were curious.
So that one is made by Eli Lilly, which makes the injectables Manjaro and Zepbound.
And they both share the same active ingredient called triazepatide.
But unlike Novo Nordisk, which took its injectable active ingredient and made it in pill form with some tweaks, Eli Lilly is doing a whole new active ingredient.
Eli Lilly isn't saying in detail yet, but I can tell you this.
It is not a peptide, so it doesn't have the same restrictions around when you need to take it.
You don't have to take it on an empty stomach and wait half an hour before eating anything.
That seems kind of nice.
Yeah.
But its approval is probably a little ways behind the Novo Nordisk pill.
And maybe here is a good place to spell out just how long the development and approval process for these drugs can be.
Hmm.
I talked to Dr. Max Denning at Eli Lilly, who's a senior medical director at the company, and worked on studying the new pill.
Actually, never.
His job was to design and oversee clinical trials for the pill and then step back.
Showing 701–720 of 1,064 · page 36 of 54 ← Previous Next →